Orris
Reading File
Running Command

python3 -c " import pdfplumber pdf_path = '/tmp/workspace/attachments/b69f2255-c4ed-4994-b7c8-935a47354a87/DOC-20260803-WA0002..pdf' with pdfplumber.open(pdf_path) as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages): text = page.extract_text() print(f'--- Page {i+1} ---') print(text[:2000] if text else '[No text extracted]') print() "

analyse_media
Reading File
Finding Sources
Searching Images

prolonged QT interval ECG 12 lead

Summary : This figure presents a 12-lead electrocardiogram (ECG) tracing from a patient with Long QT syndrome type 2, illustrating the characteristic prolonged QT interval. ecg tracing: # Leads & Layout : • Standard 12-lead ECG format: I, II, III, aVR, aVL, aVF, V1–V6. • Each lead is displayed in a horizontal row, with time progressing left to right. • Vertical grid lines represent time intervals (small squares = 0.04 s, large squares = 0.2 s). # Key Features : • Regular sinus rhythm is present. • QT interval is visibly prolonged in multiple leads (notably V2–V5). • T waves are broad and notched in some leads, consistent with Long QT syndrome type 2. • No evidence of acute ischemia, bundle branch block, or significant arrhythmia. # Technical Details : • Paper speed: standard 25 mm/s. • Amplitude: standard 10 mm/mV. • Calibration marker visible at the start of each lead row. # Analysis : • The ECG demonstrates a prolonged QT interval, a hallmark of Long QT syndrome type 2. • T wave morphology (broad, notched) is typical for this subtype. • No other acute abnormalities are apparent; the tracing is otherwise unremarkable except for the QT prolongation.

Summary : This figure presents a 12-lead electrocardiogram (ECG) tracing from a patient with Long QT syndrome type 2, illustrating the characteristic prolonged QT interval. ecg tracing: # Leads & Layout : • Standard 12-lead ECG format: I, II, III, aVR, aVL, aVF, V1–V6. • Each lead is displayed in a horizontal row, with time progressing left to right. • Vertical grid lines represent time intervals (small squares = 0.04 s, large squares = 0.2 s). # Key Features : • Regular sinus rhythm is present. • QT interval is visibly prolonged in multiple leads (notably V2–V5). • T waves are broad and notched in some leads, consistent with Long QT syndrome type 2. • No evidence of acute ischemia, bundle branch block, or significant arrhythmia. # Technical Details : • Paper speed: standard 25 mm/s. • Amplitude: standard 10 mm/mV. • Calibration marker visible at the start of each lead row. # Analysis : • The ECG demonstrates a prolonged QT interval, a hallmark of Long QT syndrome type 2. • T wave morphology (broad, notched) is typical for this subtype. • No other acute abnormalities are apparent; the tracing is otherwise unremarkable except for the QT prolongation.

A standard 12-lead electrocardiogram (ECG) demonstrating a sinus rhythm with a significantly prolonged QT interval. The QTc is calculated at 632 ms, which represents a high risk for the development of Torsades de Pointes. The T waves are notably broad and prominent across most leads, appearing upright in leads I, II, aVF, and V2-V6, while inverted in lead aVR. The QRS complexes maintain a normal duration and morphology with appropriate R-wave progression in the precordial leads (V1 to V6), showing no signs of bundle branch blocks or acute ST-segment elevation. This diagnostic image serves as a clinical example of severe drug-induced or electrolyte-related QT prolongation, commonly associated with conditions like hypokalemia or hypomagnesemia in a clinical setting. The visual illustrates the critical importance of interval measurement in ECG analysis for identifying life-threatening arrhythmia risks.

A standard 12-lead electrocardiogram (ECG) demonstrating a sinus rhythm with a significantly prolonged QT interval. The QTc is calculated at 632 ms, which represents a high risk for the development of Torsades de Pointes. The T waves are notably broad and prominent across most leads, appearing upright in leads I, II, aVF, and V2-V6, while inverted in lead aVR. The QRS complexes maintain a normal duration and morphology with appropriate R-wave progression in the precordial leads (V1 to V6), showing no signs of bundle branch blocks or acute ST-segment elevation. This diagnostic image serves as a clinical example of severe drug-induced or electrolyte-related QT prolongation, commonly associated with conditions like hypokalemia or hypomagnesemia in a clinical setting. The visual illustrates the critical importance of interval measurement in ECG analysis for identifying life-threatening arrhythmia risks.

A standard 12-lead electrocardiogram (ECG) showing a regular sinus rhythm at approximately 75 beats per minute. The primary diagnostic finding is a prolonged QT interval, with a corrected QT (QTc) calculated at 458 ms. The limb leads (I, II, III, aVR, aVL, aVF) demonstrate relatively normal axis and morphology, though the T waves appear notably tall and peaked in multiple leads. In the precordial leads (V1-V6), the QRS complexes remain narrow with a normal R-wave progression and a transition zone occurring between V3 and V4. The ST segments are isoelectric without significant elevation or depression. The tall, peaked T waves and prolonged QTc interval are the most prominent educational features, which in this clinical context may be associated with metabolic disturbances such as hypocalcemia or primary hypoparathyroidism. This ECG serves as a visual reference for diagnosing interval abnormalities and T-wave morphology variations in an acute clinical setting.

A standard 12-lead electrocardiogram (ECG) showing a regular sinus rhythm at approximately 75 beats per minute. The primary diagnostic finding is a prolonged QT interval, with a corrected QT (QTc) calculated at 458 ms. The limb leads (I, II, III, aVR, aVL, aVF) demonstrate relatively normal axis and morphology, though the T waves appear notably tall and peaked in multiple leads. In the precordial leads (V1-V6), the QRS complexes remain narrow with a normal R-wave progression and a transition zone occurring between V3 and V4. The ST segments are isoelectric without significant elevation or depression. The tall, peaked T waves and prolonged QTc interval are the most prominent educational features, which in this clinical context may be associated with metabolic disturbances such as hypocalcemia or primary hypoparathyroidism. This ECG serves as a visual reference for diagnosing interval abnormalities and T-wave morphology variations in an acute clinical setting.

Reading File
Finding Sources
I now have everything I need to provide a thorough clinical interpretation of this ECG report. Let me compose the full answer.

ECG Report Interpretation - Mrs. Maheshwari, 62F

ONECARE MEDICAL CENTER | Acquired: 3 Aug 2026, 1:06 AM

Recorded Parameters

ParameterValueNormal Range
Atrial Rate (AR)74 bpm60-100 bpm
Ventricular Rate (VR)74 bpm60-100 bpm
QRS Duration (QRSD)106 ms<120 ms
QT Interval498 ms<440 ms
QTcB (Bazett's corrected QT)553 ms<440 ms (F), <450 ms (F)
PR Interval (PRI)148 ms120-200 ms
P-R-T Axis56° / 69° / 0°P: 0-90°, QRS: 0-90°

Key Findings

1. Regular Sinus Rhythm - Normal Rate
  • AR = VR = 74 bpm, confirming 1:1 AV conduction with normal sinus rhythm.
  • PR interval of 148 ms is within normal limits (120-200 ms), so no AV block or pre-excitation.
2. QRS Duration - Borderline
  • At 106 ms, the QRS is slightly widened but below the 120 ms threshold for bundle branch block. This could represent an incomplete bundle branch block or intraventricular conduction delay - borderline finding requiring clinical correlation.
3. ⚠️ CRITICALLY ABNORMAL: Severely Prolonged QTc = 553 ms
This is the most important and concerning finding. The QTcB of 553 ms is severely prolonged and clinically significant:
  • Normal QTc for women: <450 ms
  • Borderline prolonged: 450-480 ms
  • Prolonged (moderate risk): 480-500 ms
  • Severely prolonged (high risk): >500 ms ← This patient is at 553 ms
As noted in Fuster and Hurst's The Heart, 15th Ed: "When QTc is consistently ≥500 ms, there is a 5-fold increased risk of events with a rate of 4%-5% per year." The risk for Torsades de Pointes (TdP) - a potentially fatal polymorphic ventricular tachycardia - is substantially elevated.
Tintinalli's Emergency Medicine confirms: "The risk of dysrhythmias associated with long QT syndrome increases as the QTc prolongs, with significantly higher risk when the QTc is greater than 500 ms."
4. T-Axis: 0° The T-wave axis of 0° (with QRS at 69°) suggests a wide QRS-T angle, which can be a marker of abnormal repolarization, consistent with the prolonged QTc.

Reference ECG - Prolonged QT Interval

Prolonged QT interval ECG - Long QT syndrome
Example ECG showing prolonged QT interval with broad/notched T waves, characteristic of Long QT syndrome

Differential Diagnosis for Prolonged QTc

Acquired (most common in a 62-year-old female):
  • Drug-induced (most common cause): antiarrhythmics (sotalol, amiodarone, dofetilide), antibiotics (erythromycin, clarithromycin, fluoroquinolones), antipsychotics, antidepressants (escitalopram), antifungals (fluconazole), antimalarials
  • Electrolyte disturbances: hypokalemia, hypomagnesemia, hypocalcemia
  • Cardiac conditions: acute MI, myocarditis, cardiomyopathy
  • Hypothyroidism
  • Intracranial pathology (subarachnoid hemorrhage)
Congenital:
  • Long QT Syndrome (LQTS) - less likely in a 62-year-old without prior history, but possible

Clinical Recommendations

  1. Urgent medication review - Identify and stop any QT-prolonging drugs immediately. Cross-reference against the patient's full medication list (Maudsley Guidelines lists erythromycin, clarithromycin, fluoroquinolones, chloroquine, antipsychotics, antidepressants as common offenders).
  2. Urgent electrolyte panel - Check serum K⁺, Mg²⁺, Ca²⁺ and correct any deficiencies. Hypokalemia and hypomagnesemia are common reversible causes.
  3. Full 12-lead ECG review - This report shows calculated values; the actual 12-lead tracing should be reviewed for T-wave morphology (notching, bifid T-waves), ST-segment changes, and QRS morphology.
  4. Thyroid function tests (TSH) and basic metabolic panel.
  5. Consider cardiology referral - A QTcB of 553 ms warrants specialist input. Continuous cardiac monitoring may be appropriate depending on symptoms (syncope, palpitations, near-syncope).
  6. Symptom assessment - Ask specifically about syncope, presyncope, palpitations, and family history of sudden cardiac death.
  7. Avoid triggers - Until the cause is identified, avoid QT-prolonging drugs, correct electrolytes, and advise against intense physical exertion.
Important disclaimer: This interpretation is based on the computed ECG parameters only - the actual waveform tracing was not available for visual analysis. A qualified cardiologist must review the full 12-lead ECG tracing in conjunction with the patient's clinical history, medications, and symptoms before any clinical decisions are made. The machine-calculated QTcB using Bazett's formula can overcorrect at faster heart rates - though at 74 bpm this is less of a concern here.

Clonofit

Finding Sources
Searching the Web

Clonofit clonazepam tablet uses dose side effects

Reading File
Finding Sources
Reading File
Here is a complete drug profile for Clonofit (Clonazepam):

Clonofit (Clonazepam)

Brand Names: Clonofit, Klonopin, Rivotril, Zapiz, Melzap Drug Class: Benzodiazepine | Anticonvulsant / Anxiolytic Schedule: Schedule H / Schedule IV Controlled Substance

Mechanism of Action

Clonazepam is a positive allosteric modulator of GABA-A receptors. It binds to the benzodiazepine site on the GABA-A receptor complex and increases the frequency of chloride channel opening in response to GABA - without changing channel duration. This enhances GABAergic inhibitory neurotransmission throughout the CNS, suppressing neuronal excitability and seizure propagation.
  • Plasma protein binding: ~85%
  • Half-life: 20-60 hours (mean ~30 hours) - one of the longer-acting benzodiazepines
  • Peak plasma levels: 1-4 hours after oral dosing
  • Metabolism: Hepatic - reduction of the nitro group to inactive 7-amino derivatives; less than 1% excreted unchanged in urine
(Goodman & Gilman's Pharmacological Basis of Therapeutics)

Indications

IndicationNotes
Epilepsy / SeizuresAbsence seizures, myoclonic seizures, atonic seizures, Lennox-Gastaut syndrome
Panic DisorderFDA-approved; preferred over alprazolam by some due to longer half-life and slower onset
Anxiety disordersSocial anxiety, generalized anxiety (adjunct)
REM Sleep Behavior Disorder (RBD)First-line or second-line (with melatonin)
AkathisiaRestlessness due to antipsychotic medications
Acute catatoniaShort-term management
(Textbook of Family Medicine; Bradley & Daroff's Neurology; MedlinePlus)

Dosing

IndicationAdult Starting DoseUsual RangeMax
Seizure disorders0.5 mg TID0.5-2 mg TID20 mg/day
Panic disorder0.25 mg BD0.5-2 mg/day4 mg/day
Adults (general)Should not exceed 1.5 mg/day initiallyTitrate slowlyDepends on indication
Children (seizures)0.01-0.05 mg/kg/dayDivided doses0.2 mg/kg/day
Note: Tolerance to antiseizure effects often develops after 1-6 months; some patients no longer respond at any dose after this period. (Goodman & Gilman's)

Available Formulations (Clonofit)

  • Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg
  • Liquid/oral solution also available in some markets

Side Effects

Common (dose-dependent):
  • Drowsiness / sedation (~50% of patients initially - tolerance usually develops)
  • Dizziness and unsteadiness
  • Ataxia and muscular incoordination
  • Memory problems and cognitive slowing
  • Fatigue and depression
Serious / Requiring Urgent Attention:
  • Respiratory depression - especially dangerous with opioids or alcohol (can be fatal)
  • Paradoxical disinhibition - increased agitation, aggression, impulsivity (especially in children, elderly, or those with cognitive impairment)
  • Suicidal ideation (class warning for all antiseizure medications)
  • Unusual involuntary eye movements
(Drugs.com; Goodman & Gilman's)

Important Warnings

1. Physical Dependence and Withdrawal (FDA Boxed Warning)

Dependence can occur even with short-term use (days to weeks). Abrupt discontinuation can cause:
  • Severe anxiety, insomnia, irritability
  • Tremor, sweating, confusion
  • Seizures - potentially life-threatening
  • Withdrawal symptoms can last several weeks to more than 12 months
Never stop abruptly - always taper slowly. The Maudsley Deprescribing Guidelines recommend hyperbolic dose reductions (not linear) to minimize withdrawal severity, as the dose-effect relationship is hyperbolic.

2. Opioid Combination - Black Box Warning

Combined use with opioids (codeine, morphine, oxycodone, tramadol) risks severe respiratory depression, coma, and death. Avoid combination.

3. Alcohol

Dangerous synergistic CNS/respiratory depression. Strictly avoid.

4. Tolerance

Antiseizure efficacy often diminishes after 1-6 months (tolerance). Anxiolytic efficacy can also diminish over time.

Contraindications

  • Severe hepatic impairment
  • Acute narrow-angle glaucoma
  • Myasthenia gravis
  • Severe respiratory insufficiency
  • Known hypersensitivity to benzodiazepines
  • Use in pregnancy (crosses placenta; neonatal withdrawal / "floppy infant" syndrome)

Drug Interactions

Interacting Drug/ClassEffect
OpioidsSevere CNS/respiratory depression, death
AlcoholEnhanced CNS depression
Other CNS depressants (antihistamines, antipsychotics, other benzodiazepines)Additive sedation
CYP3A4 inhibitors (ketoconazole, erythromycin, clarithromycin)Increased clonazepam levels
CYP3A4 inducers (rifampicin, phenytoin, carbamazepine)Decreased clonazepam levels
ValproateMay cause absence status epilepticus when combined

Special Populations

  • Elderly: Prolonged sedation; higher fall/fracture risk; use lowest effective dose
  • Pregnancy: Avoid if possible - neonatal withdrawal, cleft palate risk (teratogen Category D)
  • Renal impairment: Use with caution; monitor
  • Children: Efficacy established for seizures; behavioural paradoxical reactions more common

Equivalence

When switching or tapering, 1 mg clonazepam ≈ 20 mg diazepam in benzodiazepine equivalence. (Maudsley Deprescribing Guidelines)
Clinical Note (relevant to the ECG above): Clonazepam itself does not significantly prolong the QT interval and is generally considered safe from a cardiac repolarization standpoint - unlike many other psychotropics. If this patient (Mrs. Maheshwari) is being prescribed Clonofit, it is unlikely to be the cause of her prolonged QTc of 553 ms. Other medications in her regimen should be reviewed first.
This is a shared conversation. Sign in to Orris to start your own chat.